In line with these results, analysis of the in vivo experiments revealed that CTT exhibited an extreme antitumour effect on bladder cancer, and the inhibition was likely due to the inhibition of the PI3K/Akt pathway induced by the upregulation of PTEN (Figure 7). This evidence concerns the gene PTEN and urinary bladder cancer.